Immunopharmacology of a Class of Synthetics with Therapeutic Potential in Infections and Other Types of Diseases
Pharmacological modification of immune responses has been pursued in the last twenty years as a possible therapeutic modality for a number of pathologies that include neoplasia, autoimmune diseases, infections. The search for new agents has been conducted on an empirical basis using complex experimental models of possible predictive value.
KeywordsLeukemia Pseudomonas Neutropenia Cyclophosphamide Leukopenia
Unable to display preview. Download preview PDF.
- Adams D.O. and Hamilton T.A. 1984 “The cell biology of macrophage activation” p. 283–318 in Paul W.E., Fathman C.G. and Metzger H. (eds) “Ann. Rev. Immunol.” Annual Reviews Inc. U.S.A.Google Scholar
- Burkett S.K., Weaver W.M., Westall J.A., Larsen A., Kronheim S. and Wilson C.B. 1988 “Regulation of TNF and IL-1 secretion by human mononuclear phagocytes” J. Immunol. 140, p. 3473–3481.Google Scholar
- Dinarello C. 1989 “IL-1 and its biologically related cytokines” in Dixon F.J. (ed.) “Adv. in Immunol.” 44, 153–205 Academic Press, Inc.Google Scholar
- Durack D.T. 1982 “Infection in compromised hosts” p. 1713–1751 in P.J. Lachmann and D.K. Peters (eds) “Clinical aspects of immunology”, Blackwell Scientific Publications, Ltd, Oxford.Google Scholar
- Zighelboim J. 1985 “Immunobiology of Corynebacterium parvum” p. 339–354 in Mitchell M.S. (ed) “The modulation of Immunity”, Pergamon Press, Oxford.Google Scholar